Tegafur-gimeracil-oteracil Potassium

Known as: Tegafur, mixture with Gimeracil and Potassium Oxonate 
An orally bioavailable fluoropyrimidine antagonist composed of tegafur combined with two modulators of 5-fluorouracil (5-FU) activity, gimeracil and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
02420082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Interstitial lung disease (ILD) is commonly concomitant with lung cancer, and its acute exacerbation (AE) is the most… (More)
Is this relevant?
2015
2015
OBJECTIVE The aim of this study was to evaluate the therapeutic efficacy and toxicity of a combination of tegafur-gimeracil… (More)
Is this relevant?
2015
2015
BACKGROUND We investigated the efficacy and safety of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil… (More)
  • table 3
  • table 1
  • table 4
  • table 2
  • figure 1
Is this relevant?
2015
2015
Granulocyte-colony stimulating factor (G-CSF) producing pancreatic cancers are extremely rare. These tumors have an aggressive… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
BACKGROUND Tegafur-gimeracil-oteracil potassium (TS-1)is a drug that is used mainly as a third-line treatment or beyond for… (More)
Is this relevant?
2013
2013
  • Prescrire international
  • 2013
Patients with advanced-stage gastric cancer and inoperable locoregional extension rarely survive more than a few months… (More)
Is this relevant?
Review
2013
Review
2013
Oral fluoropyrimidine anticancer agents (oral 5-fluorouracil [5-FU]) able to be used as chemotherapy for breast cancer include… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
OBJECTIVE The safety profiles of oral fluoropyrimidines were compared with 5-fluorouracil (5-FU) using adverse event reports… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
2. Maciejowska E, Jablonska S, Chorzelski T. Is pemphigus herpetiformis an entity? Int J Dermatol 1987;26:571-7. 3. Jablonska S… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
A 70-year-old woman who underwent proximal gastrectomy for gastric cancer (poorly-differentiated adenocarcinoma) of Stage IIIB at… (More)
Is this relevant?